ARPELOS

ARPELOS

Multivalent medicines that deliver transformative outcomes

Multivalent medicines that deliver transformative outcomes

Multivalent medicines that deliver transformative outcomes

At Arpelos, we’re engineering targeted therapeutics that achieve unprecedented potency and selectivity. We’re a dynamic, nimble team spanning compute, immunology, and protein engineering hailing from UCSF, Penn, Stanford, and MIT.


We’re a Seed-stage biotech company based in Kendall Square supported by top biotech investors. Our mission is to create diverse and differentiated medicines to impact millions of patients.

At Arpelos, we’re engineering targeted therapeutics that achieve unprecedented potency and selectivity. We’re a dynamic, nimble team spanning compute, immunology, and protein engineering hailing from UCSF, Penn, Stanford, and MIT.


We’re a Seed-stage biotech company based in Kendall Square supported by top biotech investors. Our mission is to create diverse and differentiated medicines to impact millions of patients.

At Arpelos, we’re engineering targeted therapeutics that achieve unprecedented potency and selectivity. We’re a dynamic, nimble team spanning compute, immunology, and protein engineering hailing from UCSF, Penn, Stanford, and MIT.


We’re a Seed-stage biotech company based in Kendall Square supported by top biotech investors. Our mission is to create diverse and differentiated medicines to impact millions of patients.

collaborate@arpelos.com
© 2025 Arpelos Biosciences, Inc.

collaborate@arpelos.com
© 2025 Arpelos Biosciences, Inc.